Remove Avalon Remove Capital Remove Company Remove Startup
article thumbnail

Avalon Ventures: Startups Get Milestone Payments, New Company Launched With GSK

socalTECH

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration.

Avalon 113
article thumbnail

Avalon Ventures, GlaxoSmithKline Team On Two New Startups

socalTECH

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.

Avalon 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avalon Ventures Launches Trio Of Life Science Startups

socalTECH

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100
article thumbnail

Avalon Ventures Raises $201.6M As Part Of $250M Venture Fund

socalTECH

In what is a rarity nowadays for a Southern California venture capital fund, San Diego- and Cambridge-based venture capital firm Avalon Ventures has just closed on $201.6M in commitments for a $250M fund, Avalon Ventures X. The funding was disclosed via a regulatory filing Thursday. READ MORE>>.

Avalon 184
article thumbnail

Janux Therapeutics Prices IPO, Hits Nasdaq Today

socalTECH

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113
article thumbnail

Core Innovation Capital Sets Up Shop In LA

socalTECH

In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. The fund has not yet announced local investments, but has been actively talking to companies fitting its investment profile. READ MORE>>.

Capital 174
article thumbnail

Fortis Therapeutics Gets $40M For Cancer Treatments

socalTECH

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113